1. Home
  2. MDGL vs OLLI Comparison

MDGL vs OLLI Comparison

Compare MDGL & OLLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • OLLI
  • Stock Information
  • Founded
  • MDGL 2011
  • OLLI 1982
  • Country
  • MDGL United States
  • OLLI United States
  • Employees
  • MDGL N/A
  • OLLI N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • OLLI Department/Specialty Retail Stores
  • Sector
  • MDGL Health Care
  • OLLI Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • OLLI Nasdaq
  • Market Cap
  • MDGL 6.8B
  • OLLI 6.6B
  • IPO Year
  • MDGL N/A
  • OLLI 2015
  • Fundamental
  • Price
  • MDGL $267.56
  • OLLI $110.88
  • Analyst Decision
  • MDGL Strong Buy
  • OLLI Buy
  • Analyst Count
  • MDGL 10
  • OLLI 14
  • Target Price
  • MDGL $420.63
  • OLLI $124.07
  • AVG Volume (30 Days)
  • MDGL 367.0K
  • OLLI 1.1M
  • Earning Date
  • MDGL 05-01-2025
  • OLLI 06-03-2025
  • Dividend Yield
  • MDGL N/A
  • OLLI N/A
  • EPS Growth
  • MDGL N/A
  • OLLI 10.62
  • EPS
  • MDGL N/A
  • OLLI 3.23
  • Revenue
  • MDGL $317,383,000.00
  • OLLI $2,271,705,000.00
  • Revenue This Year
  • MDGL $285.43
  • OLLI $15.77
  • Revenue Next Year
  • MDGL $63.77
  • OLLI $11.60
  • P/E Ratio
  • MDGL N/A
  • OLLI $34.32
  • Revenue Growth
  • MDGL N/A
  • OLLI 8.04
  • 52 Week Low
  • MDGL $200.63
  • OLLI $73.36
  • 52 Week High
  • MDGL $377.46
  • OLLI $122.15
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 31.79
  • OLLI 47.75
  • Support Level
  • MDGL $281.76
  • OLLI $113.14
  • Resistance Level
  • MDGL $295.60
  • OLLI $116.59
  • Average True Range (ATR)
  • MDGL 12.60
  • OLLI 3.80
  • MACD
  • MDGL -2.58
  • OLLI 0.07
  • Stochastic Oscillator
  • MDGL 3.22
  • OLLI 37.94

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About OLLI Ollie's Bargain Outlet Holdings Inc.

Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name brand household related items that consumers use in their everyday lives at prices that are heavily discounted below traditional retailers. It offers customers a broad selection of brand name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.

Share on Social Networks: